跳至主要内容
临床试验/IRCT20090801002266N20
IRCT20090801002266N20尚未招募3 期

Investigating the effect of ketamine on the severity of pain in patients with somatic symptoms disorder with pain predominance: a randomized controlled trial

Esfahan University of Medical Sciences0 个研究点目标入组 84 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Diagnosis of somatic symptom disorder with obvious pain complaint based on DSM-V criteria
  • Informed consent to participate in the study
  • Age group 18-60 years
  • No history of mania/hypomania
  • No presence of symptoms of psychosis in the patient's current or past history
  • No history of drug dependence or abuse in the last 3 months
  • No Pregnancy or lactation
  • No Serious and uncontroled physical patients, including liver, kidney, digestive, respiratory, cardiovascular (such as ischemic heart diseases), endocrine, neurological, increased intraocular pressure or increased cerebrospinal fluid pressure, hematological (on Based on the history of the patient and companions, and if needed, paraclinical examination and consultation)
  • No taking any kind of medicine that is prohibited to use at the same time as ketamine
  • Untreated hypothyroidism or hyperthyroidism. (due to the instability of physical and vital signs)

排除标准

  • Emergence of psychosis and psychotic symptoms
  • Patients who became out of reach of the researcher in the follow-up process
  • Annoying and uncontrollable side effects with ketamine use

研究者

相似试验